4.5 Review

Extracellular vesicles derived from mesenchymal stem cells - a novel therapeutic tool in infectious diseases

Journal

INFLAMMATION AND REGENERATION
Volume 43, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s41232-023-00266-6

Keywords

Mesenchymal stem cells; Extracellular vesicles; Wound infections; Exosomes; Stem cell therapy

Ask authors/readers for more resources

Extracellular vesicles (EVs) are cell-derived nano-sized lipid-bilayer encapsulated vesicles released into the surrounding space, playing an important role in intercellular communication. In treating infectious diseases, mesenchymal stem cell-derived EVs (MSC-EVs) have shown therapeutic value by eliminating pathogens, modulating resistance, and repairing tissue damage. This is achieved by producing antimicrobial substances, inhibiting pathogen multiplication, and activating macrophage phagocytic activity. EVs also play a key role in infectious pathogenesis and hold great promise for innovative treatments.
Extracellular vesicles (EVs) are nano-sized lipid-bilayer encapsulated vesicles produced by the cells. These EVs are released into the surrounding space by almost all cell types. The EVs help in intercellular communication via their payloads which contain various proteins, lipids, and nucleic acids generated from the donor cells and allow for synergistic responses in surrounding cells. In recent years, EVs have been increasingly important in treating infectious diseases, including respiratory tract infections, urinary tract infections, wound infections, sepsis, and intestinal infections. Studies have confirmed the therapeutic value of mesenchymal stem cell-derived EVs (MSC-EVs) for treating infectious diseases to eliminate the pathogen, modulate the resistance, and restore tissue damage in infectious diseases. This can be achieved by producing antimicrobial substances, inhibiting pathogen multiplication, and activating macrophage phagocytic activity. Pathogen compounds can be diffused by inserting them into EVs produced and secreted by host cells or by secreting them as microbial cells producing EVs carrying signalling molecules and DNA shielding infected pathogens from immune attack. EVs play a key role in infectious pathogenesis and hold great promise for developing innovative treatments. In this review, we discuss the role of MSC-EVs in treating various infectious diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available